Prasol Chemicals Profit Soars 151% on Pricing Windfall
The specialty chemical maker's first post-IPO quarter saw revenue jump 36%, but a large one-off gain from inventory accounted for much of the margin surge.
Prasol Chemicals reported a 151% jump in Q1 FY27 net profit to ₹61 crore, driven by strong volume growth and a one-time pricing benefit. Management expects margins to normalize as the geopolitical tailwind fades.
Prasol Chemicals entered the public markets with a quarter that showcased both its underlying growth and a significant, temporary boost. The specialty chemical maker’s first results since its September 2026 IPO revealed a business scaling up, but one where a geopolitical pricing windfall flattered the headline profit surge.
Revenue for the quarter ended June 2026 rose to ₹433.7 crore, a 36% increase from a year ago and a 29% jump from the previous quarter. Profit soared even higher, climbing 151% year-on-year and over 200% sequentially to ₹61 crore. This pushed the net profit margin to 14.1%, a sharp expansion from 7.6% a year earlier.
Revenue (₹ Cr)
Profit (₹ Cr)
Net Profit Margin
| Metric | CurrentQ1 FY27 | PreviousQ4 FY26 | Same quarter LYQ1 FY26 |
|---|---|---|---|
| Period | Jun 2026 | Mar 2026 | Jun 2025 |
| Revenue (₹ Cr) | 433.65YoY +36% | 337.18 | 319.56 |
| Profit (₹ Cr) | 61.02YoY +151% | 19.86 | 24.34 |
| Net Profit Margin | 14.1%YoY +86% | 5.9% | 7.6% |
The one-off behind the surge
The dramatic margin expansion had a clear driver beyond operational improvements. According to reports from ScanX and Flash Finance, about ₹25 crore of the quarter’s gross profit came from a one-time inventory gain. Geopolitical tensions disrupted supply chains, allowing Prasol to sell inventory purchased at lower prices into a rising market, particularly for acetone-based products.
Management was explicit that this benefit is not recurring. Their guidance for the full FY27 excludes this ₹25 crore gain and a smaller forex benefit, pointing to a normalized EBITDA margin range of 15-16%. ScanX notes this implies an operational EBITDA margin of around 15.1% for Q1, closely aligning with the full-year outlook.
A foundation of real growth
Beneath the pricing spike, the business showed healthy progress. Reports from Arthneeti and Multibagg.ai attribute the revenue growth to steady volume increases, a better product mix, and higher realizations. A key operational win was the turnaround at the Mahad facility, which recorded its best-ever quarterly production.
Live Chart
· PRASOLCHEM
(BSE)
ISIN: INE455U01024
The company is now virtually net debt-free after using ₹60 crore from IPO proceeds to repay borrowings, as noted by Flash Finance. This strengthens the balance sheet for an ambitious expansion. Management has outlined a two-phase capex plan totaling ₹500-600 crore over the coming years, aiming to nearly double capacity and target revenue of ₹2,800-3,000 crore within five years.
Key Points
- Prasol’s Q1 net profit jumped 151% YoY to ₹61 crore, with revenue up 36% to ₹433.7 crore.
- A one-time ₹25 crore inventory gain from geopolitical supply disruptions significantly boosted quarterly margins, which management expects to normalize.
- Underlying growth was driven by volume gains, an improved product mix, and a profitability turnaround at the Mahad plant.
- The company is now nearly debt-free post-IPO and has outlined a ₹500-600 crore expansion plan to drive long-term growth.
Hexa Perspective
This quarter presents a clear case of separating the transient from the structural. The inventory gain provided a exceptional, non-recurring lift to profitability that investors should not extrapolate. The more durable story is the operational scaling—better plant utilization and a richer product mix—which supports the guided 15-16% EBITDA margin.
The coming quarters will test whether the company can maintain this underlying momentum as the pricing tailwind fades. Success will hinge on executing its capacity expansion and continuing to shift its portfolio toward higher-value derivatives, all while navigating the raw material volatility inherent in the chemicals sector.
Also read
Want this applied to your portfolio?
Talk to a HexaWealth advisor, or sync your mutual fund data for insights tailored to your holdings.